Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.40B.
ENTERPRISE VALUE (EV)
$1.40B
Collegium Pharmaceutical, Inc.
Market Cap
$717.44M
Enterprise Value (EV)
$1.40B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Collegium Pharmaceutical, Inc. (COLL) | $717.44M | $1.40B |
| Avalo Therapeutics, Inc. (AVTX)vs › | $719.59M | $634.45M |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $714.33M | $666.39M |
| Cytek Biosciences, Inc. (CTKB)vs › | $720.94M | $673.55M |
| Achieve Life Sciences, Inc. (ACHV)vs › | $736.49M | $703.48M |
| Faeth Therapeutics, Inc. (FTH)vs › | $737.40M | $711.09M |
| Candel Therapeutics, Inc. (CADL)vs › | $744.71M | $592.66M |
| Anteris Technologies Global Corp. (AVR)vs › | $689.73M | $435.66M |
| Helus Pharma Inc. (HELP)vs › | $684.07M | $517.90M |
| Annexon, Inc. (ANNX)vs › | $677.49M | $502.87M |
Market Cap
$717.44M
Total Debt
$936.43M
Cash
$251.10M
Enterprise Value
$1.40B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
